Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Common Stock of Tvardi Therapeutics, Inc. · CUSIP: 140755208

Event date: 2025-04-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Solas Tvardi Sidecar LLC

    Shares: 761,287.00 · Class: 8.1%

  • Solas BioVentures Fund II, LP

    Shares: 761,287.00 · Class: 8.1%

  • Solas Partners II, LLC

    Shares: 761,287.00 · Class: 8.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002049793-25-000001
Form type
SCHEDULE 13G
Filer
Solas Tvardi Sidecar LLC
CIK
CIK 2049793
Filed
Apr 22, 2025
Reporting period
Apr 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub